Themis Medicare Beheer
Beheer criteriumcontroles 3/4
De CEO Themis Medicare is Sachin Patel, benoemd in Feb2017, heeft een ambtstermijn van 7.75 jaar. De totale jaarlijkse vergoeding van { bedraagt ₹ 26.21M, bestaande uit 77.1% salaris en 22.9% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 5.99% van de aandelen van het bedrijf, ter waarde ₹ 1.63B. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7.8 jaar en 3 jaar.
Belangrijke informatie
Sachin Patel
Algemeen directeur
₹26.2m
Totale compensatie
| Percentage CEO-salaris | 77.1% |
| Dienstverband CEO | 7.8yrs |
| Eigendom CEO | 6.0% |
| Management gemiddelde ambtstermijn | 7.8yrs |
| Gemiddelde ambtstermijn bestuur | 3yrs |
Recente managementupdates
Recent updates
What Themis Medicare Limited's (NSE:THEMISMED) 42% Share Price Gain Is Not Telling You
Dec 27
Themis Medicare (NSE:THEMISMED) Takes On Some Risk With Its Use Of Debt
Dec 01Themis Medicare (NSE:THEMISMED) Has Affirmed Its Dividend Of ₹5.00
Aug 18Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00
Aug 04Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00
Jul 18We Think Themis Medicare (NSE:THEMISMED) Is Taking Some Risk With Its Debt
Jul 08Themis Medicare (NSE:THEMISMED) Is Due To Pay A Dividend Of ₹5.00
May 18Themis Medicare (NSE:THEMISMED) Seems To Use Debt Quite Sensibly
Dec 21Themis Medicare (NSE:THEMISMED) Has Announced That It Will Be Increasing Its Dividend To ₹5.00
Aug 28Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹5.00
Aug 08Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's
Jul 21Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's
May 27Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?
May 12Calculating The Fair Value Of Themis Medicare Limited (NSE:THEMISMED)
Nov 09Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?
Oct 26Increases to Themis Medicare Limited's (NSE:THEMISMED) CEO Compensation Might Cool off for now
Sep 11Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹4.30
Aug 16Do Themis Medicare's (NSE:THEMISMED) Earnings Warrant Your Attention?
Jul 09Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹530m |
| Jun 30 2024 | n/a | n/a | ₹500m |
| Mar 31 2024 | ₹26m | ₹20m | ₹435m |
| Dec 31 2023 | n/a | n/a | ₹453m |
| Sep 30 2023 | n/a | n/a | ₹512m |
| Jun 30 2023 | n/a | n/a | ₹577m |
| Mar 31 2023 | ₹21m | ₹13m | ₹569m |
| Dec 31 2022 | n/a | n/a | ₹584m |
| Sep 30 2022 | n/a | n/a | ₹576m |
| Jun 30 2022 | n/a | n/a | ₹591m |
| Mar 31 2022 | ₹13m | ₹7m | ₹729m |
| Dec 31 2021 | n/a | n/a | ₹710m |
| Sep 30 2021 | n/a | n/a | ₹703m |
| Jun 30 2021 | n/a | n/a | ₹591m |
| Mar 31 2021 | ₹7m | ₹7m | ₹357m |
| Dec 31 2020 | n/a | n/a | ₹349m |
| Sep 30 2020 | n/a | n/a | ₹338m |
| Jun 30 2020 | n/a | n/a | ₹274m |
| Mar 31 2020 | ₹7m | ₹7m | ₹248m |
| Dec 31 2019 | n/a | n/a | ₹61m |
| Sep 30 2019 | n/a | n/a | -₹45m |
| Jun 30 2019 | n/a | n/a | -₹64m |
| Mar 31 2019 | ₹7m | ₹7m | -₹107m |
| Dec 31 2018 | n/a | n/a | ₹54m |
| Sep 30 2018 | n/a | n/a | ₹78m |
| Jun 30 2018 | n/a | n/a | ₹101m |
| Mar 31 2018 | ₹6m | ₹6m | ₹113m |
Compensatie versus markt: De totale vergoeding ($USD 310.96K ) Sachin } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 271.25K ).
Compensatie versus inkomsten: De vergoeding van Sachin is het afgelopen jaar met meer dan 20% gestegen.
CEO
Sachin Patel (49 yo)
7.8yrs
Tenure
₹26,206,000
Compensatie
Dr. Sachin Dinesh Patel, Ph D., CChem. has been Chief Executive Officer and Managing Director of Themis Medicare Limited since February 14, 2017.He served as Deputy Managing Director at Themis Medicare Lt...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman | 17.4yrs | ₹26.21m | 10.55% ₹ 2.9b | |
| CEO, MD & Executive Director | 7.8yrs | ₹26.21m | 5.99% ₹ 1.6b | |
| VP of Systems & Administration and Alternate Non-Executive Non-Independent Director | no data | geen gegevens | 4.04% ₹ 1.1b | |
| Chief Financial Officer | 8.1yrs | ₹2.27m | geen gegevens |
7.8yrs
Gemiddelde duur
Ervaren management: Het managementteam van THEMISMED is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman | 17.4yrs | ₹26.21m | 10.55% ₹ 2.9b | |
| CEO, MD & Executive Director | 17.4yrs | ₹26.21m | 5.99% ₹ 1.6b | |
| VP of Systems & Administration and Alternate Non-Executive Non-Independent Director | 1.2yrs | geen gegevens | 4.04% ₹ 1.1b | |
| Non-Executive Director | 17.6yrs | ₹410.00k | 15.78% ₹ 4.3b | |
| Independent Director | 3yrs | ₹660.00k | geen gegevens | |
| Independent Director | 1.2yrs | ₹200.00k | geen gegevens | |
| Additional Independent Woman Director | 4yrs | ₹130.00k | geen gegevens | |
| Non-Executive Non-Independent Director | 1.2yrs | geen gegevens | geen gegevens | |
| Independent Director | less than a year | geen gegevens | 0.0054% ₹ 1.5m |
3.0yrs
Gemiddelde duur
68yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van THEMISMED wordt beschouwd als ervaren (gemiddelde ambtstermijn 3 jaar).